SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
HUT

Hut 8 Corp. (NASDAQ:HUT)

US · Delayed Price · Currency is USD
Also listed: HUT.TOFinancial Services · Financial - Capital Markets
64.17+2.94 (+4.81%)
 
Market cap
$7.91B
Health Score
Analyst consensus
Listed since
Mar 8, 2018
Website
Insider Score
––Not scored
HUT Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

HUT analyst forecast

HUT analyst consensus

Moderate Buy8 ratings
Buy 8 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

HUT 12-month price target

$197.00+213.4% upsideaverage of 4 firms
$275.00High
$143.00Low

Best analysts covering HUT

  • Needham100%success rate · 12 calls
  • Benchmark100%success rate · 10 calls
  • Cantor Fitzgerald100%success rate · 3 calls
  • Rosenblatt100%success rate · 2 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

HUT analyst ratings

FirmPrice targetAction
—Piper SandlerOverweight——Reiterated2026-10-20
—Cantor FitzgeraldOverweight——Reiterated2026-10-16
Morgan StanleyOverweight$275.00+237.7%Reiterated2026-10-12
—Canaccord GenuityBuy——Reiterated2026-10-07
UBS—$143.00+34.1%—2026-09-23
Wells Fargo—$175.00+94.8%—2026-09-17
Coker Palmer—$195.00+102.8%—2026-09-08
—Keefe, Bruyette & WoodsOutperform——Reiterated2026-08-06
—Piper SandlerOverweight——Reiterated2026-08-06
—RosenblattBuy——Reiterated2026-08-05
—NeedhamBuy——Reiterated2026-08-05
—B. Riley SecuritiesBuy——Reiterated2026-08-03
—Keefe, Bruyette & WoodsOutperform——Reiterated2026-07-28
—BenchmarkBuy——Reiterated2026-07-22
—RosenblattBuy——Reiterated2026-07-21
—NeedhamBuy——Reiterated2026-07-20
—BenchmarkBuy——Reiterated2026-07-14
—BTIGBuy——Reiterated2026-06-25
—RosenblattBuy——Reiterated2026-06-11
—B. Riley SecuritiesBuy——Reiterated2026-05-13
—RosenblattBuy——Reiterated2026-05-08
—Canaccord GenuityBuy——Reiterated2026-05-07
—CitizensMarket Outperform——Reiterated2026-05-07
—NeedhamBuy——Reiterated2026-05-07
—BTIGBuy——Reiterated2026-05-06
—Piper SandlerOverweight——Reiterated2026-05-06
—BTIGBuy——Reiterated2026-04-24
—Piper SandlerOverweight——Reiterated2026-04-21
—Cantor FitzgeraldOverweight——Reiterated2026-04-09
—Canaccord GenuityBuy——Reiterated2026-02-27
—HC Wainwright & Co.Buy——Reiterated2026-02-26
—RosenblattBuy——Reiterated2026-02-26
—NeedhamBuy——Reiterated2026-02-26
—Keefe, Bruyette & WoodsOutperform——Reiterated2026-01-27
—NeedhamBuy——Reiterated2026-01-16
—B. Riley SecuritiesBuy——Reiterated2026-01-09
—Keefe, Bruyette & WoodsOutperform——Reiterated2025-12-19
—NeedhamBuy——Reiterated2025-12-18
—RosenblattBuy——Reiterated2025-12-18
—Canaccord GenuityBuy——Reiterated2025-12-18
—BTIGBuy——Reiterated2025-12-17
—BTIGBuy——Reiterated2025-11-06
—Canaccord GenuityBuy——Reiterated2025-11-05
—RosenblattBuy——Reiterated2025-11-05
—Cantor FitzgeraldOverweight——Reiterated2025-11-04
—BenchmarkBuy——Reiterated2025-10-28
—JMP SecuritiesMarket Outperform——Reiterated2025-10-21
—RosenblattBuy——Reiterated2025-10-16
—BTIGBuy——Reiterated2025-10-14
—Roth CapitalBuy——Reiterated2025-09-15
—BTIGBuy——Reiterated2025-09-09
—Canaccord GenuityBuy——Reiterated2025-08-20
—RosenblattBuy——Reiterated2025-08-11
—Maxim GroupBuy——Reiterated2025-08-11
—Canaccord GenuityBuy——Reiterated2025-05-12
—HC Wainwright & Co.Buy——Reiterated2025-05-09
—NeedhamBuy——Reiterated2025-05-09
—BenchmarkBuy——Reiterated2025-04-02
—Cantor FitzgeraldOverweight——Reiterated2025-03-07
—NeedhamBuy——Reiterated2025-03-04

HUT earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-02-25-0.15-2.42$93.0M$88.5M
2026-05-06-0.33-1.98$78.5M$71.0M
2026-08-04-0.55-1.27$79.4M$74.9M
2026-11-04-0.750.00$76.5M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.